The current financial score of Rapid Micro Biosystems Inc is 5.12. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 8.05M, representing a year-over-year increase of 10.91%, while its net profit experienced a year-over-year increase of 8.98%.
The current valuation score of Rapid Micro Biosystems Inc is 7.75. Its current P/E ratio is -1.03, which is -49.95% below the recent high of -0.52 and -353.75% above the recent low of -4.69.
The current earnings forecast score of Rapid Micro Biosystems Inc is 8.50. The average price target is 6.67, with a high of 8.00 and a low of 5.00.
The current price momentum score of Rapid Micro Biosystems Inc is 5.46. Currently, the stock price is trading between the resistance level at 1.55 and the support level at 0.95, making it suitable for range-bound swing trading.
The current institutional shareholding score of Rapid Micro Biosystems Inc is 5.00. The latest institutional shareholding proportion is 60.78%, representing a quarter-over-quarter increase of 3.40%. The largest institutional shareholder is James Simons, holding a total of 212.10K shares, representing 0.00% of shares outstanding, with 14.25% increase in holdings.
The current risk assessment score of Rapid Micro Biosystems Inc is 3.02. The company's beta value is 1.47. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.